Clearstead Advisors, LLC Gossamer Bio, Inc. Transaction History
Clearstead Advisors, LLC
- $6.44 Billion
- Q4 2024
A detailed history of Clearstead Advisors, LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 22,000 shares of GOSS stock, worth $30,579. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,000
Previous 22,000
-0.0%
Holding current value
$30,579
Previous $21,000
9.52%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GOSS
# of Institutions
116Shares Held
163MCall Options Held
821KPut Options Held
557K-
Octagon Capital Advisors LP New York, NY18.4MShares$25.5 Million3.68% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$25.1 Million1.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$13.9 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL8.81MShares$12.2 Million0.03% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$11.2 Million4.56% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $131M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...